A Noninterventional Study of Vimpat (Lacosamide) as Adjunctive Antiepileptic Drug Therapy in Patients With Brain Tumor-related Epilepsy
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Acronyms VIBES
- Sponsors UCB
- 05 Dec 2017 Status changed from active, no longer recruiting to completed.
- 05 Sep 2017 Planned End Date changed from 1 Jan 2018 to 1 Dec 2017.
- 05 Sep 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Dec 2017.